# GLP-1 physiology informs the pharmacotherapy of obesity

Review · Daniel J. Drucker

- Archive id: doi:10.1016/j.molmet.2021.101351
- Published: 2021-10-08
- Venue: Molecular Metabolism
- DOI: https://doi.org/10.1016/j.molmet.2021.101351
- PMID: 34626851
- Citations: 508
- Source URL: https://doi.org/10.1016/j.molmet.2021.101351
- PDF: https://www.sciencedirect.com/science/article/pii/S2212877821001988/pdf
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

Cited in dossiers:
- [GLP-1 & Incretin Therapies: State of the Field (October 2026)](https://space-kitty.com/dossiers/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.